Skip to main navigation
  • News
  • Careers
  • Contact Us
  • Get Email Alerts
  • ADMA BioCenters
  • About us
    • Our Company
      • About ADMA Biologics
      • What We Do
      • Advocacy
      • Business Ethics & Compliance
    • Our People
      • Senior Leadership Team
      • Board of Directors
      • Scientific Advisory Board
  • Science & Technology
    • Plasma & IVIG
      • Our Patented Immunotechnology
      • About Plasma & IVIG
    • Medical Affairs
      • Medical Affairs Overview
      • Publications
    • Primary Immunodeficiency Disease
      • About Primary Immunodeficiency Disease (PI)
  • Our Products
    • Our Products
      • Asceniv
      • Bivigam®
      • Nabi-HB®
  • Manufacturing
    • Manufacturing Process
    • Contract Manufacturing
  • Investors
    • Overview
    • Press Releases
      • Press Releases
      • Email Alerts
    • Company Info
      • Company Information
      • Corporate Presentation
      • Management Team
      • Contacts
      • FAQs
    • Analyst Coverage
      • Analyst Coverage
    • Events & Webcasts
      • Events & Webcasts
    • Financial Info
      • Financial Information
      • Financial Results
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Annual Reports
    • Stock Info
      • Stock Data & Quote
      • Historical Data
    • SEC Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Documents
  • News
  • Careers
  • Contact Us
  • Get Email Alerts
  • ADMA BioCenters
ADMA logo ADMA logo
  • About Us
    • Our Company
      • About ADMA Biologics
      • Advocacy
      • What We Do
      • Business Ethics & Compliance
    • Our People
      • Senior Leadership Team
      • Board of Directors
      • Scientific Advisory Board
  • Science & Technology
    • Plasma & IVIG
      • Our Patented Immunotechnology
      • About Plasma & IVIG
    • Primary Immunodeficiency Disease
      • About Primary Immunodeficiency Disease (PI)
    • Medical Affairs
      • Medical Affairs Overview
      • Publications
  • Our Products
    • OUR PRODUCTS
      • Overview
    • PRODUCT WEBSITES
      • Asceniv™
      • Bivigam®
      • Nabi-HB®
  • Manufacturing
    • PROCESS & CAPABILITIES
      • Manufacturing Process
      • Contract Manufacturing Capabilities
  • Investors
    • Press Releases
      • Press Releases
      • Email Alerts
    • Financial Info
      • Financial Information
      • Financial Results
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Annual Reports
    • Company Info
      • Company Information
      • Corporate Presentation
      • Management Team
      • Contacts
      • FAQs
    • Stock Info
      • Stock Data & Quote
      • Historical Data
    • Analyst Coverage
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Events & Webcasts
      • Events & Webcasts
    • Governance
      • Board of Directors
      • Board Committees
      • Documents
Our Company
  • About ADMA Biologics
  • Advocacy
  • What We Do
  • Business Ethics & Compliance
Our People
  • Senior Leadership Team
  • Board of Directors
  • Scientific Advisory Board
Plasma & IVIG
  • Our Patented Immunotechnology
  • About Plasma & IVIG
Primary Immunodeficiency Disease
  • About Primary Immunodeficiency Disease (PI)
Medical Affairs
  • Medical Affairs Overview
  • Publications
OUR PRODUCTS
  • Overview
PRODUCT WEBSITES
  • Asceniv™
  • Bivigam®
  • Nabi-HB®
PROCESS & CAPABILITIES
  • Manufacturing Process
  • Contract Manufacturing Capabilities
Press Releases
  • Press Releases
  • Email Alerts
Financial Info
  • Financial Information
  • Financial Results
  • Balance Sheet
  • Income Statement
  • Cash Flow
  • Annual Reports
Company Info
  • Company Information
  • Corporate Presentation
  • Management Team
  • Contacts
  • FAQs
Stock Info
  • Stock Data & Quote
  • Historical Data
Analyst Coverage
  • Analyst Coverage
SEC Filings
  • SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Section 16 Filings
Events & Webcasts
  • Events & Webcasts
Governance
  • Board of Directors
  • Board Committees
  • Documents

Press Releases

ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
Aug 09, 2023
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
Aug 02, 2023
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
Jul 19, 2023
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Mar 23, 2023
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
Mar 16, 2023
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
Feb 08, 2023
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
Jan 17, 2023
ADMA Biologics, Inc. logo footer
© Copyright ADMA Biologics, Inc.
Ramsey, NJ Offices  | 201-478-5552
Boca Raton, FL Offices  |  561-989-5800
info@admabio.com
    • About Us
    • Science & Technology
    • Our Products
    • Manufacturing
    • Investors
    • Connect With Us
    • Email Alerts
    • RSS
    • Careers
    • HCP Disclosure Reporting
    • Cookie Policy
    • ADMA BioCenters
    • Contact Us
    • Privacy Policy
    • Disclaimer
    • Site Map